PVLA: Pieris Pharmaceuticals Company Short-Term Debt
The price history of Pieris Pharmaceuticals (PVLA) reflects the situation of a company lacking its own revenue and relying on external financing, with the indicator standing at 0.00. The business focuses on creating synthetic anticalins for inhalation lung therapy. The issuer's future depends on a revision of its development strategy and the search for major partners to cover research costs and replenish reserves.
Metric breakdowns and analytics for Pieris Corp (PVLA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Pieris Pharmaceuticals|PVLA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Pieris Pharmaceuticals|PVLA - Company Total Debt|Debt to Book Capitalization Ratio Pieris Pharmaceuticals, Inc.|PVLA - Company Long-Term Liabilities|Company Current Liabilities Pieris Pharmaceuticals|Quick Liquidity pieris.com
- net income and valuation multiples indicators:
Initial company analysis:PVLA - Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals (PVLA) is implementing closed-loop water systems and reducing toxic emissions as part of its ESG strategy. The modernization of biotechnological facilities requires precise liquidity control to service current obligations. This metric aggregates the total amount of all loans and borrowings with a maturity of up to one year. It measures short-term financial stability and default risk. By analyzing fluctuations in short-term debt, an investor assesses the company's efficiency in managing working capital.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Current Liabilities ZBIO|IMNM: Company Short-Term Debts|GOSS - Short-Term Debt Volume|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ANAB (AnaptysBio, Inc.)|Short-Term Debt Volume astriatx.com (ATXS)|ENGN - Company Short-Term Debt|Short-Term Debt Volume rapt.com RAPT|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt Kyverna Therapeutics|tizianalifesciences.com - Current Liabilities|Company Short-Term Debts CABA|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Debts Avalo Therapeutics Inc AVTX|ELDN - Company Short-Term Debt|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|Climb Bio (CLYM) - Company Short-Term Debt|Company Current Liabilities zurabio.com|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts Adagene Corp|Company Short-Term Debts IMA|Company Current Liabilities shattucklabs.com STTK|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|IMUX: Company Current Liabilities|ATRA - Company Short-Term Debts|IFRX (inflarx.de) - Company Current Liabilities|XFOR: Amount of Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debt|ENLV: Company Short-Term Debt|q32bio.com (QTTB) - Company Short-Term Debt|GOVX - Short-Term Debt Volume|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com - Current Liabilities|Company Current Liabilities CARM (Carisma Therapeutics)|Company Short-Term Debt XTLB (XTL Biopharmaceuticals Ltd)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCW Biologics, Inc. - Company Short-Term Debt|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc